[Predictors of Coronary Plaque Vulnerability in Patients with Stable Coronary Artery Disease]

N A Kochergin1, A M Kochergina1, V I Ganyukov1

  • 1Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo.

Kardiologiia
|November 24, 2020
PubMed

Insights

Vulnerable atherosclerotic plaques are common in stable ischemic heart disease patients. Dyslipidemia and blood glucose levels correlate with plaque vulnerability, offering new predictors for risk assessment.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biochemistry

Background:

  • Atherosclerotic coronary plaques can become vulnerable, leading to adverse cardiovascular events.
  • Identifying predictors of plaque vulnerability is crucial for managing stable ischemic heart disease (sIHD).

Purpose of the Study:

  • To identify novel predictors for the vulnerability of atherosclerotic coronary plaques in patients with sIHD.
  • To investigate the association between inflammation, dyslipidemia, and carbohydrate metabolism markers with coronary plaque vulnerability.

Main Methods:

  • Prospective, single-center study involving 58 patients with sIHD.
  • Virtual histology intravascular ultrasound was used to detect unstable plaques in coronary arteries without significant lesions.
  • Candidate predictors included indexes of inflammation, dyslipidemia, and carbohydrate metabolism.

Main Results:

  • 12 out of 58 detected plaques (20.7%) were classified as vulnerable.
  • Vulnerable plaques exhibited larger necrotic cores, more calcified nodules, and less fibrous components compared to stable plaques.
  • Higher prevalence of vulnerable plaques was associated with significant arterial lumen narrowing (>70% lumen area).
  • Negative correlations were found between high-density lipoproteins (HDL) and calcium volume, and between apolipoprotein A and calcium volume.
  • A positive correlation was observed between oral glucose tolerance test (OGTT) blood glucose levels and the lipid component of plaques.

Conclusions:

  • A high prevalence of vulnerable coronary plaques exists in non-target arteries of sIHD patients.
  • Dyslipidemia markers (LDL, apolipoproteins A) correlate with plaque calcium volume.
  • Blood glucose levels, assessed via OGTT, correlate with the lipid component of coronary plaques, suggesting their role as potential vulnerability predictors.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
217
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
484
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
232
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
503
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
135